⌘K

Login Start Free

Home/Filings/4/A/0001235641-03-000007

4/A//SEC Filing

CLARK DAVID L 4/A

Accession 0001235641-03-000007

CIK 0000890465other

View on SEC.gov Company Profile

Filed

Sep 14, 8:00 PM ET

Accepted

Sep 15, 6:56 PM ET

Size

11.1 KB

Accession

0001235641-03-000007

Insider Transaction Report

Form 4/AAmended

Period: 2003-09-10

NPS PHARMACEUTICALS INCNPSP

VP, Corporate Affairs

Transactions

Exercise/Conversion
Common Stock
2003-09-10$4.50/sh+800$3,600→ 4,131 total
Exercise/Conversion
Stock Option
2003-09-10$4.50/sh−800$3,600→ 1,200 total
Exercise: $4.50From: 2000-12-08Exp: 2009-12-08→ Common Stock (800 underlying)
Exercise/Conversion
Stock Option
2003-09-10$6.63/sh−3,600$23,850→ 4,500 total
Exercise: $6.63From: 1999-12-04Exp: 2008-12-04→ Common Stock (3,600 underlying)
Sale
Common Stock
2003-09-10$30.91/sh−11,600$358,605→ 3,331 total
Exercise/Conversion
Stock Option
2003-09-10$10.75/sh−7,200$77,400→ 4,400 total
Exercise: $10.75From: 2001-05-24Exp: 2010-05-24→ Common Stock (7,200 underlying)
Exercise/Conversion
Common Stock
2003-09-10$6.63/sh+3,600$23,850→ 7,731 total
Exercise/Conversion
Common Stock
2003-09-10$10.75/sh+7,200$77,400→ 14,931 total

Footnotes (1)

[F1]This transaction was executed under a Rule 10b5-1 trading plan.

Documents

1 file

4
edgar.xml
PRIMARY DOCUMENT

Issuer

NPS PHARMACEUTICALS INC

CIK 0000890465

Entity typeother

Related Parties

1

filerCIK 0001235641

Filing Metadata

Form type: 4/A
Filed: Sep 14, 8:00 PM ET
Accepted: Sep 15, 6:56 PM ET
Size: 11.1 KB

View on SEC.gov